Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells-Reference-Cited by-同舟云学术

Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells

Published:2018-04-26 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Truffi Marta,Colombo Miriam,Sorrentino Luca,Pandolfi Laura,Mazzucchelli Serena^ORCID,Pappalardo Francesco,Pacini Chiara,Allevi Raffaele,Bonizzi Arianna,Corsi Fabio,Prosperi Davide

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-24968-x.pdf

Reference32 articles.

1. Xuan, Q. et al. Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes. Breast Cancer Res Treat. 150(3), 581–588 (2015).

2. Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785), 177–82 (1987).

3. Slamon, D. et al. Adjuvant trastuzumab in HER-2 positive breast cancer. N Engl J Med 365(14), 1273–83 (2011).

4. Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344, 783–792 (2001).

5. Vogel, C. L. et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20, 719–726 (2002).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron oxide nanoparticles: The versatility of the magnetic and functionalized nanomaterials in targeting drugs, and gene deliveries with effectual magnetofection;Journal of Drug Delivery Science and Technology;2024-09

2. Endosomal escape in magnetic nanostructures: Recent advances and future perspectives;Materials Today Advances;2024-06

3. A Short Appraisal of Magnetic Nanoparticles for Breast Cancer: In vitro and In vivo Research;Recent Patents on Nanotechnology;2024-06

4. A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment;Journal of Drug Delivery Science and Technology;2024-05

5. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy;Current Medicinal Chemistry;2024-02